A Study of the Safety and Tolerability of IBI321 in Patients With Advanced Solid Tumors
Clinical trial NCT04911881 · COMPLETED
Trial details
- NCT number
- NCT04911881
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-24
- Primary completion
- 2023-02-23
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.